Navigating the financial aspects of healthcare can be daunting, especially when it comes to important diagnostic tests. If you’re considering hereditary cancer testing through Quest Diagnostics, understanding your payment options is crucial. A common question many patients ask is: Does Quest Diagnostics take CareCredit? Let’s delve into the financial assistance and payment solutions offered by Quest Diagnostics to clarify your choices.
Quest Diagnostics is committed to making essential hereditary cancer testing accessible. They understand that cost can be a significant concern, and therefore, they offer a range of financial support programs to help patients manage expenses. While the direct answer to whether Quest Diagnostics explicitly lists CareCredit as a payment option might require direct verification with Quest Diagnostics, it’s important to explore the broader financial assistance they provide.
To ensure patients aren’t surprised by high out-of-pocket costs, Quest Diagnostics proactively works to verify insurance coverage. Upon receiving your order and blood sample, their team assesses your insurance plan to estimate your potential expenses. For significant costs, particularly exceeding $100 for Hereditary Breast Cancer Panels or Comprehensive and Guideline-Based Hereditary Cancer Panels, they aim to notify you or your healthcare provider before proceeding with the test. This proactive approach allows for informed decisions about continuing or cancelling the test based on financial considerations.
Recognizing that financial constraints can prevent access to vital testing, Quest Diagnostics has established a dedicated Financial Assistance Program. This program is designed to significantly reduce out-of-pocket expenses for eligible patients. For those who qualify based on income, the program can cap expenses at $200 for a range of hereditary cancer tests. Specifically, patients with a household income at or below 400% of the federal poverty level may be eligible for this reduced cost.
Furthermore, Quest Diagnostics extends support to uninsured and underinsured individuals. Patients with income at or below the federal poverty level may even receive testing at no charge. For those needing further flexibility, Quest Diagnostics offers 0% financing payment plans for up to 12 months, making payments more manageable over time.
The Financial Assistance Program applies to a comprehensive list of hereditary cancer tests, including:
- Comprehensive Hereditary Cancer Panel
- Guideline-Based Hereditary Cancer Panel
- Hereditary Breast Cancer Panel
- Hereditary Colorectal Cancer Panel
- Hereditary Endocrine Cancer Panel
- BRCA Panel Plus
- BRCA Panel (BRCA1, BRCA2)
- BRCA Ashkenazi Jewish Screen
- BRCA Ashkenazi Jewish Screen w/Reflex to BRCA Panel (BRCA1, BRCA2)
- BRCA1 and BRCA2 Deletion and Duplication
- Lynch Syndrome Panel
- Nevoid Basal Cell Carcinoma (NBCCS) (Gorlin) Syndrome Panel (PTCH1, SUFU)
- Tuberous Sclerosis Complex Panel (TSC1, TSC2)
- Juvenile Polyposis Panel (BMPR1A, SMAD4)
- Hereditary Cancer Single-site(s) test
- Hereditary Cancer Single-gene tests
While information on CareCredit acceptance requires direct confirmation with Quest Diagnostics, exploring their Financial Assistance Program and contacting them directly at 1.866.GENE.INFO (1.866.436.3463) is the best course of action to understand all available payment options and ensure you can access the hereditary cancer testing you need. They are dedicated to providing solutions to make these vital tests financially accessible.
